Alexian Brothers Neurosciences Institute
Alexian Brothers Hospital Network Selected for National Neurostimulation Depression Study -
Study to Add to Body of Research for Patients Suffering from Depression
ST. PAUL , Minn. – April 21, 2008 – St. Jude Medical, Inc. (NYSE:STJ) today announced it has been awarded a patent from the U.S. Patent and Trademark Office for treating depression using neurostimulation therapy in an area of the brain known as Brodmann Area 25. It is the focus of the St. Jude Medical BROADEN™ (BROdmann Area 25 DEep brain Neuromodulation) study, which is evaluating whether deep brain stimulation (DBS) therapy can help people who suffer from major depressive disorder, a severe form of depression... More
Alexian Brothers Unveils Chicagoland's Most Advanced Brain Mapping
The Alexian Brothers Hospital Network has unveiled new leading-edge brain mapping technology in the Chicago area with the acquisition of a whole-head Magnetoencephalography [MEG] system from Elekta. The Elekta Neuromag® system is a highly sophisticated device for measuring the magnetic signals generated by the electrical activity of brain... More
Alexian compassion enables Bolivian to receive advanced brain treatment
Sergio Jimenez's headaches were so painful that he couldn't go to work. As they worsened, he experienced blurred vision and dizziness. One day, his father visited him at his apartment in La Paz, Bolivia... More
Alexian Brothers Hospital Network Partners With American Stroke Association To Support Stroke Survivors
The Alexian Brothers Hospital Network and the American Stroke Association have joined forces to promote a statewide supportive community of stroke... More
